10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2012 | |||
Consolidated Statements Of Income | |||
Period Ending Dec 31, 2012 10-K (Filed: Feb 22, 2013) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
| Revenues | |||
| Premiums | $ 56,496,700 | 55,969,600 | 53,973,600 |
| Administrative fees | 3,934,100 | 3,854,600 | 3,730,400 |
| Other revenue | 297,700 | 41,000 | 36,500 |
| Total operating revenue | 60,728,500 | 59,865,200 | 57,740,500 |
| Net investment income | 686,100 | 703,700 | 803,300 |
| Net realized gains on investments | 334,900 | 235,100 | 194,100 |
| Other than temporary impairment losses on investments | |||
| Total other-than-temporary impairment losses on investments | (41,200) | (114,700) | (70,800) |
| Portion of other-than-temporary impairment losses recognized in other comprehensive income | 3,400 | 21,400 | 31,400 |
| Other-than-temporary impairment losses recognized in income | (37,800) | (93,300) | (39,400) |
| Total revenues | 61,711,700 | 60,710,700 | 58,698,500 |
| Expenses | |||
| Benefit expense | 48,213,600 | 47,647,500 | 44,930,400 |
| Selling, general and administrative expense: | |||
| Selling expense | 1,586,900 | 1,616,800 | 1,610,300 |
| General and administrative expense | 7,151,400 | 6,818,800 | 7,122,300 |
| Total selling, general and administrative expense | 8,738,300 | 8,435,600 | 8,732,600 |
| Cost of products sold | 137,400 | 0 | 0 |
| Interest expense | 511,800 | 430,300 | 418,900 |
| Amortization of other intangible assets | 245,100 | 239,400 | 241,700 |
| Impairment of other intangible assets | 0 | 0 | 21,100 |
| Total expenses | 57,846,200 | 56,752,800 | 54,344,700 |
| Income before income tax expense | 3,865,500 | 3,957,900 | 4,353,800 |
| Income tax expense | 1,210,000 | 1,311,200 | 1,466,700 |
| Net income | 2,655,500 | 2,646,700 | 2,887,100 |
| Net income per share | |||
| Basic | 8.2600 | 7.3500 | 7.0300 |
| Diluted | 8.1800 | 7.2500 | 6.9400 |
| Dividends per share | 1.1500 | 1.0000 | 0.0000 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2012 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2012 10-K (Filed: Feb 22, 2013) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
| Net income | $ 2,655,500 | 2,646,700 | 2,887,100 |
| Change in net unrealized gains/losses on investments | 189,900 | 20,600 | 125,100 |
| Change in non-credit component of other-than-temporary impairment losses on investments | 4,500 | (700) | 14,700 |
| Change in net unrealized gains/losses on cash flow hedges | 100 | (10,000) | (14,500) |
| Change in net periodic pension and postretirement costs | (10,900) | (119,800) | 32,900 |
| Foreign currency translation adjustments | 600 | 200 | (1,700) |
| Other comprehensive income (loss) | 184,200 | (109,700) | 156,500 |
| Total comprehensive income | 2,839,700 | 2,537,000 | 3,043,600 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2012 | |||
Consolidated Statements Of Cash Flows | |||
Period Ending Dec 31, 2012 10-K (Filed: Feb 22, 2013) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2012 | Dec 31, 2011 | Dec 31, 2010 | |
| Operating activities | |||
| Net income | $ 2,655,500 | 2,646,700 | 2,887,100 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Net realized gains/losses on investments | (334,900) | (235,100) | (194,100) |
| Other-than-temporary impairment losses recognized in income | 37,800 | 93,300 | 39,400 |
| Loss on disposal of assets | 4,700 | 3,300 | 1,900 |
| Deferred income taxes | 127,500 | 74,300 | 101,800 |
| Amortization, net of accretion | 633,600 | 541,500 | 497,700 |
| Impairment of goodwill and other intangible assets | 0 | 0 | 21,100 |
| Depreciation expense | 107,100 | 95,700 | 103,100 |
| Impairment of property and equipment | 66,800 | 0 | 95,300 |
| Share-based compensation | 146,500 | 134,800 | 136,000 |
| Excess tax benefits from share-based compensation | (28,800) | (42,200) | (28,100) |
| Changes in operating assets and liabilities, net of effect of business combinations: | |||
| Receivables, net | 189,900 | (401,800) | 109,700 |
| Other invested assets | (38,900) | (8,900) | 5,100 |
| Other assets | 79,200 | (259,200) | (320,100) |
| Policy liabilities | (53,700) | 978,000 | (330,700) |
| Unearned income | (193,700) | 35,100 | (158,600) |
| Accounts payable and accrued expenses | (406,500) | (208,700) | (58,200) |
| Other liabilities | (132,800) | (13,600) | (208,400) |
| Income taxes | (73,900) | (44,600) | (1,239,800) |
| Other, net | (40,800) | (14,200) | (43,500) |
| Net cash provided by operating activities | 2,744,600 | 3,374,400 | 1,416,700 |
| Investing activities | |||
| Purchases of fixed maturity securities | (15,040,400) | (11,914,800) | (10,567,200) |
| Proceeds from fixed maturity securities: | |||
| Sales | 13,675,900 | 10,446,200 | 7,215,100 |
| Maturities, calls and redemptions | 1,781,500 | 1,891,300 | 3,321,700 |
| Purchases of equity securities | (292,600) | (355,600) | (350,900) |
| Proceeds from sales of equity securities | 422,700 | 287,400 | 197,900 |
| Purchases of other invested assets | (303,700) | (207,900) | (91,400) |
| Proceeds from sales of other invested assets | 35,500 | 29,400 | 34,500 |
| Changes in securities lending collateral | 307,900 | 28,900 | (504,800) |
| Purchases of subsidiaries, net of cash acquired | (4,597,000) | (600,000) | (300) |
| Purchases of property and equipment | (544,900) | (519,500) | (451,400) |
| Proceeds from sales of property and equipment | 400 | 3,700 | 800 |
| Other, net | 3,100 | (31,100) | (75,500) |
| Net cash (used in) provided by investing activities | (4,551,600) | (942,000) | (1,271,500) |
| Financing activities | |||
| Net proceeds from (repayments of) commercial paper borrowings | (229,000) | 463,600 | (164,400) |
| Proceeds From Issuance Of Long Term Debt | 6,468,900 | 1,097,400 | 1,088,500 |
| Repayments of long-term borrowings | (1,251,300) | (705,100) | (481,700) |
| Proceeds from short-term borrowings | 642,000 | 100,000 | 100,000 |
| Repayments of short-term borrowings | (492,000) | (100,000) | 0 |
| Changes in securities lending payable | (307,800) | (29,000) | 504,900 |
| Changes in bank overdrafts | (17,600) | 264,300 | (28,000) |
| Repurchase and retirement of common stock | (2,496,800) | (3,039,800) | (4,360,300) |
| Cash dividends | (367,100) | (357,800) | 0 |
| Proceeds from exercise of employee stock options | 110,800 | 245,000 | 143,600 |
| Excess tax benefit from share baed compensation | 28,800 | 42,200 | 28,100 |
| Net cash used in financing activities | 2,088,900 | (2,019,200) | (3,169,300) |
| Effect of foreign exchange rates on cash and cash equivalents | 1,100 | (400) | (3,200) |
| Change in cash and cash equivalents | 283,000 | 412,800 | (3,027,300) |
| Cash and cash equivalents at beginning of year | 2,201,600 | 1,788,800 | |
| Cash and cash equivalents at end of year | 2,484,600 | 2,201,600 | 1,788,800 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ELEVANCE HEALTH, INC. | ||
Ticker: ELV Fiscal Year: 2012 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2012 10-K (Filed: Feb 22, 2013) | ||
| (In Thousands, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2012 | Dec 31, 2011 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 2,484,600 | 2,201,600 |
| Investments available-for-sale, at fair value: | ||
| Fixed maturity securities (amortized cost of $16,033.1 and $15,233.6) | 16,912,900 | 15,913,100 |
| Equity securities (cost of $869.9 and 937.7) | 1,212,400 | 1,188,100 |
| Other invested assets, current | 14,800 | 14,800 |
| Accrued investment income | 162,200 | 172,000 |
| Premium and self-funded receivables | 3,687,400 | 3,402,900 |
| Other receivables | 928,800 | 943,900 |
| Income taxes receivable | 228,500 | 105,800 |
| Securities lending collateral | 564,600 | 871,400 |
| Deferred tax assets, net | 243,200 | 424,800 |
| Other current assets | 1,829,000 | 1,859,000 |
| Total current assets | 28,268,400 | 27,097,400 |
| Long-term investments available-for-sale, at fair value: | ||
| Fixed maturity securities (amortized cost of $426.0 and $240.8) | 431,500 | 246,800 |
| Equity securities (cost of $27.1 and $28.4) | 30,100 | 28,800 |
| Other invested assets, long-term | 1,387,700 | 1,103,300 |
| Property and equipment, net | 1,738,300 | 1,418,100 |
| Goodwill | 17,510,500 | 13,858,700 |
| Other intangible assets | 9,102,800 | 7,931,700 |
| Other noncurrent assets | 486,100 | 478,400 |
| Total assets | 58,955,400 | 52,163,200 |
| Liabilities and shareholders' equity | ||
| Medical claims payable | 6,174,500 | 5,489,000 |
| Reserves for future policy benefits | 61,300 | 55,100 |
| Other policyholder liabilities | 2,345,700 | 2,278,200 |
| Total policy liabilities | 8,581,500 | 7,822,300 |
| Unearned income | 968,300 | 926,500 |
| Accounts payable and accrued expenses | 3,132,500 | 3,124,100 |
| Security trades pending payable | 69,300 | 51,700 |
| Securities lending payable | 564,700 | 872,500 |
| Short-term borrowings | 250,000 | 100,000 |
| Current portion of long-term debt | 557,100 | 1,274,500 |
| Other current liabilities | 1,713,500 | 1,727,100 |
| Total current liabilities | 15,836,900 | 15,898,700 |
| Long-term debt, less current portion | 14,170,800 | 8,465,700 |
| Reserves for future policy benefits, noncurrent | 750,800 | 730,700 |
| Deferred tax liabilities, net | 3,381,000 | 2,724,000 |
| Other noncurrent liabilities | 1,013,200 | 1,055,900 |
| Total liabilities | 35,152,700 | 28,875,000 |
| Commitments and contingencies-Note 14 | ||
| Shareholders' equity | ||
| Preferred stock, without par value, shares authorized-100,000,000; shares issued and outstanding-none | 0 | 0 |
| Common stock, par value $0.01, shares authorized-900,000,000; shares issued and outstanding: 304,715,144 and 339,372,680 | 3,000 | 3,400 |
| Additional paid-in capital | 10,853,500 | 11,679,200 |
| Retained earnings | 12,647,100 | 11,490,700 |
| Accumulated other comprehensive income | 299,100 | 114,900 |
| Total shareholders' equity | 23,802,700 | 23,288,200 |
| Total liabilities and shareholders' equity | 58,955,400 | 52,163,200 |
| External Links | |
| ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2012 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |